Business Health Industry News

Global Stem Cell Treatment Market is expected to thrive at a CAGR of 36.52% by 2022

Press Release

The Global Stem Cell Treatment Market was valued at US$ 1313.72 million in 2016 and is expected to reach US$ 4759.27 Billion by 2022 growing at a CAGR of 36.52% during the forecast period. Stem-cell therapy is the use of stem cells to treat, prevent and control a disease or condition. Bone marrow transplant is the very widely-used stem cell therapy, followed by several therapies that are derived from umbilical cord blood.

Augmentation in research studies aim at broadening the utility scope of associated products is anticipated to drive the market growth in recent years. These research projects have opened the possibility of implementation of several clinical applications of these cells, thereby directly influencing disease-modifying treatments.

Request For Free Sample @

Market Dynamics
Stem cells have tremendous promise to help us understand and treat, monitor and control a range of diseases, injuries and other health-related conditions. Their potential is evident with the use of blood stem cells to treat diseases of the blood, a therapy that has saved the lives of thousands of children with leukemia; and can be seen in the use of stem cells for tissue grafts to treat and further control diseases or injury to the bone, skin and surface of the eye. Important clinical trials involving stem cells are underway for many other conditions and researchers continue to explore new parades using stem cells in medicine.

Market Segmentation
The stem cell treatment market is segmented on the basis of type, therapeutic application, treatment, and geography.
1. On the basis of type
Allogeneic stem cell therapy: The segment is expected to command the largest share in the global stem cell therapy market in 2016. This large share can primarily be ascribed to the rising commercialization of allogeneic stem cell therapy products, wider therapeutic applications of allogeneic stem cells, easy production scale-up process, and growing number of clinical trials and researches related to allogeneic stem cell therapies.
Autologous stem cell therapy: Here, a patient’s own blood-formingstem cells are collected. He or she is then treated with high doses of chemotherapy, or a combination of chemotherapy and radiation. The high-dose treatment kills cancer cells, and additionally, also eliminates the blood-producing cells that are left in the bone marrow.

2.On the basis of therapeutic application
Musculoskeletal disorders
Wounds and injuries
Cardiovascular diseases
Gastrointestinal diseases

Regional/Geographic Analysis
North America is expected to be the largest regional segment in the global stem cell therapy market in 2016 attributing to the technological advancements, followed by Asia-Pacific and Rest of the World.

Buy This Premium Report Now @

Key players
Some of the major players in the market include NuVasive, Inc. (U.S.), Holostem Terapie Avanzate S.r.l. (Italy), MEDIPOST Co. Ltd. (South Korea), Anterogen Co. Ltd. (South Korea), Pharmicell Co. Ltd. (South Korea), JCR Pharmaceuticals Co. Ltd. (Japan), RTI Surgical Inc. (U.S.), and AlloSource (U.S.), etc.

The report contains comprehensive analysis on:
Stem Cell Treatment Market Segments
Stem Cell Treatment Market Drivers, Restraints and Opportunities
Stem Cell Treatment Market Size & Forecast 2016 to 2022
Supply & Demand Value Chain
Stem Cell Treatment Market Current Trends
Competition &Major Companies
Technology and R&D Status
Porters Five Force Analysis
Strategic and Critical Success Factor Analysis of Key Players
Regional analysis for Stem Cell Treatment Market includes
North America
US and Canada
Latin America
Mexico, Brazil, Argentina and Rest of Latin America
Western Europe
EU5 (Germany, France, Italy, Spain, U.K.)
Nordic Countries (Denmark, Finland, Norway, and Sweden)
Benelux (Belgium, The Netherlands, and Luxembourg)
Rest of Western Europe
Eastern Europe
Rest of Eastern Europe
Asia Pacific
Australia and New Zealand
Rest of Asia Pacific
Middle East and Africa
GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
South Africa
North Africa
Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides in-depth market segmentation that is derived from extensive product mapping exercises, macro-economic factors and other qualitative and quantitative insights. The impact of all such factors are delivered across multiple market segments and geographies.

Report Highlights:
Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
Consumer and Pricing Analysis
Market dynamics of the industry
In-depth Market Segmentation
Historical and Projected Market Sizing in terms of volume and value
Recent market trends and Impact Factors
R&D Status and Technology Overview
Extensive Industry Structure Coverage

Read More @

About Kenneth Research:

Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation.

Contact Us

Name:  David

Email: [email protected]

Phone: +1 313 462 0609